Recursion Pharmaceuticals, Inc. (BMV:RXRX)
89.00
+5.01 (5.96%)
At close: Dec 4, 2025
| Market Cap | 44.67B |
| Revenue (ttm) | 801.35M |
| Net Income (ttm) | -13.12B |
| Shares Out | n/a |
| EPS (ttm) | -32.72 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 180 |
| Average Volume | 29,851 |
| Open | 89.00 |
| Previous Close | 83.99 |
| Day's Range | 89.00 - 89.00 |
| 52-Week Range | 70.95 - 219.00 |
| Beta | n/a |
| RSI | 46.18 |
| Earnings Date | Feb 27, 2026 |